New Products In Brief
This article was originally published in The Gray Sheet
Executive Summary
Sequenom’s Down syndrome test
You may also be interested in...
New Products In Brief
A drug-eluting stent and prostate cancer assay are among newly approved devices.
News In Brief
InSightec submits ExAblate PMA to treat pain caused by bone metastases. AngioDynamics initiates NanoKnife software recall. Sequenom raises $62 million in secondary stock offering. More news briefs.
Segasist Awaits 510(k) Clearance For "Self-Training" Auto-Contouring Tool
Segasist expects FDA to decide as early as this month on a 510(k) submission for a prostate-contouring software system designed to "learn" as it goes and become more and more accurate the more it is used.